Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Retinal disease in the C3 glomerulopathies and the risk of impaired vision.

Savige J, Amos L, Ierino F, Mack HG, Symons RC, Hughes P, Nicholls K, Colville D.

Ophthalmic Genet. 2016 Dec;37(4):369-376.

PMID:
26915021
2.

Careful cone counting critical for clinical care.

Metha A, Symons RA.

Clin Exp Ophthalmol. 2014 Dec;42(9):807-9. doi: 10.1111/ceo.12460. No abstract available.

PMID:
25521579
3.

Incidence and clinical predictors of ocular candidiasis in patients with Candida fungemia.

Khalid A, Clough LA, Symons RC, Mahnken JD, Dong L, Eid AJ.

Interdiscip Perspect Infect Dis. 2014;2014:650235. doi: 10.1155/2014/650235.

4.

Bilateral retrobulbar optic neuropathy in the setting of interferon alpha-2a therapy.

Fuzzard DR, Mack HG, Symons RC.

Case Rep Ophthalmol. 2014 Aug 27;5(2):270-6. doi: 10.1159/000366407.

5.

Cytokine profiles in clinical subtypes of ophthalmic Graves' disease.

Linquist RA, Symons RC, O'Bryhim B, Whittaker TJ, Sokol JA.

Orbit. 2014 Oct;33(5):363-8. doi: 10.3109/01676830.2014.937877.

PMID:
25058606
6.

CHD7 deficiency in "Looper", a new mouse model of CHARGE syndrome, results in ossicle malformation, otosclerosis and hearing impairment.

Ogier JM, Carpinelli MR, Arhatari BD, Symons RC, Kile BT, Burt RA.

PLoS One. 2014 May 19;9(5):e97559. doi: 10.1371/journal.pone.0097559.

7.

Honokiol inhibits pathological retinal neovascularization in oxygen-induced retinopathy mouse model.

Vavilala DT, O'Bryhim BE, Ponnaluri VK, White RS, Radel J, Symons RC, Mukherji M.

Biochem Biophys Res Commun. 2013 Sep 6;438(4):697-702. doi: 10.1016/j.bbrc.2013.07.118.

PMID:
23921228
8.

The genetic control of avascular area in mouse oxygen-induced retinopathy.

O'Bryhim BE, Radel J, Macdonald SJ, Symons RC.

Mol Vis. 2012;18:377-89.

9.

Spectral- and time-domain optical coherence tomography measurements of macular thickness in normal eyes and in eyes with diabetic macular edema.

Ibrahim MA, Sepah YJ, Symons RC, Channa R, Hatef E, Khwaja A, Bittencourt M, Heo J, Do DV, Nguyen QD.

Eye (Lond). 2012 Mar;26(3):454-62. doi: 10.1038/eye.2011.293.

10.

Comparison of film and digital fundus photographs in eyes of individuals with diabetes mellitus.

Gangaputra S, Almukhtar T, Glassman AR, Aiello LP, Bressler N, Bressler SB, Danis RP, Davis MD; Diabetic Retinopathy Clinical Research Network..

Invest Ophthalmol Vis Sci. 2011 Aug 3;52(9):6168-73. doi: 10.1167/iovs.11-7321.

11.

RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027.

Kaiser PK, Symons RC, Shah SM, Quinlan EJ, Tabandeh H, Do DV, Reisen G, Lockridge JA, Short B, Guerciolini R, Nguyen QD; Sirna-027 Study Investigators..

Am J Ophthalmol. 2010 Jul;150(1):33-39.e2. doi: 10.1016/j.ajo.2010.02.006.

PMID:
20609706
12.

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study.

Nguyen QD, Shah SM, Heier JS, Do DV, Lim J, Boyer D, Abraham P, Campochiaro PA; READ-2 Study Group..

Ophthalmology. 2009 Nov;116(11):2175-81.e1. doi: 10.1016/j.ophtha.2009.04.023.

PMID:
19700194
13.

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).

Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Charlton-Menys V, DeMicco DA, Fuller JH; CARDS Investigators..

Am J Kidney Dis. 2009 Nov;54(5):810-9. doi: 10.1053/j.ajkd.2009.03.022.

PMID:
19540640
14.

Solar maculopathy in a young child.

Symons RC, Mainster MA, Goldberg MF.

Br J Ophthalmol. 2010 Sep;94(9):1258-9, 1269. doi: 10.1136/bjo.2008.154450. No abstract available.

PMID:
19188195
15.

Common ophthalmic emergencies.

Khare GD, Symons RC, Do DV.

Int J Clin Pract. 2008 Nov;62(11):1776-84. doi: 10.1111/j.1742-1241.2008.01855.x. Review.

PMID:
19143862
16.

Accidental Nd:YAG laser-induced choroidal neovascularization.

Ying HS, Symons RC, Lin KL, Solomon SD, Gehlbach PL.

Lasers Surg Med. 2008 Apr;40(4):240-2. doi: 10.1002/lsm.20626.

PMID:
18412221
17.

Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration.

Nguyen QD, Shah SM, Hafiz G, Do DV, Haller JA, Pili R, Zimmer-Galler IE, Janjua K, Symons RC, Campochiaro PA.

Am J Ophthalmol. 2008 Feb;145(2):257-266.

18.

No maternally inherited diabetes and deafness mutations in a sample of 193 Tasmanian diabetics with glaucoma.

Symons RC, Turakulov R, Foote SJ, Craig JE, McCartney PJ, Mackey DA.

Ophthalmic Genet. 2007 Mar;28(1):39-41. No abstract available.

PMID:
17454746
19.

Differential sensitivity of cones to iron-mediated oxidative damage.

Rogers BS, Symons RC, Komeima K, Shen J, Xiao W, Swaim ME, Gong YY, Kachi S, Campochiaro PA.

Invest Ophthalmol Vis Sci. 2007 Jan;48(1):438-45.

PMID:
17197565
20.

Dynamic and quantitative analysis of choroidal neovascularization by fluorescein angiography.

Shah SM, Tatlipinar S, Quinlan E, Sung JU, Tabandeh H, Nguyen QD, Fahmy AS, Zimmer-Galler I, Symons RC, Cedarbaum JM, Campochiaro PA.

Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5460-8.

PMID:
17122137
Items per page

Supplemental Content

Loading ...
Support Center